title: Survey on cannabis use in Parkinson's disease: subjective improvement of motor symptoms.
abstract: An anonymous questionnaire sent to all patients attending the Prague Movement Disorder Centre revealed that 25% of 339 respondents had taken cannabis and 45.9% of these described some form of benefit.
authors.affiliation: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic.
authors.forename: Katerina
authors.initials: K
authors.lastname: Venderová
authors.forename: Evzen
authors.initials: E
authors.lastname: Růzicka
authors.forename: Viktor
authors.initials: V
authors.lastname: Vorísek
authors.forename: Peter
authors.initials: P
authors.lastname: Visnovský
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002186:Cannabinoids / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D002189:Marijuana Abuse / Q000453:epidemiology*; D008875:Middle Aged; D010300:Parkinson Disease / Q000175:diagnosis* / Q000453:epidemiology*; D015995:Prevalence; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
chemical_list: D002186:Cannabinoids